ZoomMed Announces its Intention to Proceed With a Private Placement of $2.5 Million
03 Février 2011 - 4:30PM
Marketwired
ZoomMed Inc. (TSX VENTURE: ZMD) announces that it has taken the
steps in order to conclude a brokered private placement of units,
at a subscription price of $0.155 per unit, for a maximum amount of
$2,500,000 (the "Units") with investors, subject to the approval of
the TSX Venture Exchange and others regulatory authorities. The
broker appointed for this private placement is Avenue Capital
Markets Inc.
Each Unit consists of one common share of ZoomMed Inc. ("Common
Share") and one half- warrant. Each whole warrant entitles the
holder thereof to purchase one Common Share at an exercise price of
$0.155 for a period of 24 months from the date of the closing of
the financing. All of the Common Shares and warrants that may be
issued are subject to a mandatory holding period of 4 months and 1
day from the date of the closing of the financing.
About ZoomMed
ZoomMed's developed the ZRx Prescriber, a technological
innovative Web application that enables physicians to use a
wireless device, such as the IPod Touch™, IPhone™, IPad™, Google
Android™, other PDA's or computers, to write and rapidly deliver
scripts. The ZRx Prescriber is quick, efficient and intuitive.
Since it is a stand-alone product, it can easily be integrated to
any Electronic Medical Record application (EMR).
About Praxis Sante
PraxisLab is a new application that enhances all aspects of the
prescription filling process and the complete pharmacists patient
file management. Fast, efficient and user friendly, its unique
development concept provides a fast access to all its
functionalities, thus allowing its users to be productive with a
minimum training. PraxisLab uses state-of-the-art protocols and
up-to-date software standards, allowing high compatibility with
existing software, as well as new generation software.
For further information about Praxis Sante Inc., please visit
the Web Site; www.praxissante.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Contacts: ZoomMed Inc. Mr. Yves Marmet President and Chief
Executive Officer 450-678-5457, Ext 228 info@zoommed.com
www.zoommed.com
Zoommed (TSXV:ZMD)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Zoommed (TSXV:ZMD)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024